Skip to main content
Fig. 4 | Journal of Genetic Engineering and Biotechnology

Fig. 4

From: Production of polyclonal antibody against the recombinant PirBvp protein of Vibrio parahaemolyticus

Fig. 4

Dot blotting for antibody specificity (a), sensitivity (b) and ELISA for antibody sensitivity (c). (a) a: V. alginolyticus, b: V. cholera, c: V. vulnificus, d: VPnon-AHPND (XN8), e: White Spot Syndrome virus, f: bovine serum albumin, g: VPAHPND (XN89), h: purified recombinant PirBvp protein. b a1: VPnon-AHPND (XN8), a2-8: purified rPirBvp protein with 2-fold diluted concentration from 200-3.125 ng/mL, b1: bovine serum albumin, b2-8: native PirBvp of VPAHPND (XN89) with 2-fold diluted concentration from 200 to 3.125 ng/mL

Back to article page